These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29216902)
21. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa. Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970 [TBL] [Abstract][Full Text] [Related]
22. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions. More SA; Atal S; Mishra PS J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933 [TBL] [Abstract][Full Text] [Related]
23. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study. Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785 [TBL] [Abstract][Full Text] [Related]
24. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. Geer MI; Koul PA; Tanki SA; Shah MY J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493 [TBL] [Abstract][Full Text] [Related]
25. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India. Sharma A; Kumari KM; Manohar HD; Bairy KL; Thomas J Perspect Clin Res; 2015; 6(2):109-15. PubMed ID: 25878957 [TBL] [Abstract][Full Text] [Related]
26. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012. Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567 [TBL] [Abstract][Full Text] [Related]
27. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
28. Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs. Kane-Gill SL; Forsberg EA; Verrico MM; Handler SM Drug Saf; 2012 Aug; 35(8):645-53. PubMed ID: 22720659 [TBL] [Abstract][Full Text] [Related]
29. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study. Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234 [TBL] [Abstract][Full Text] [Related]
30. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database. Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262 [TBL] [Abstract][Full Text] [Related]
31. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR. Khan LM; Al-Harthi SE; Saadah OI Saudi Pharm J; 2013 Jul; 21(3):261-6. PubMed ID: 23960842 [TBL] [Abstract][Full Text] [Related]
32. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study. Kumar R; Jindal A; Garg P; Kaur A; Kumar S; Tilak Raj R; Singh S Cureus; 2023 Sep; 15(9):e44984. PubMed ID: 37822427 [TBL] [Abstract][Full Text] [Related]
33. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. Thiesen S; Conroy EJ; Bellis JR; Bracken LE; Mannix HL; Bird KA; Duncan JC; Cresswell L; Kirkham JJ; Peak M; Williamson PR; Nunn AJ; Turner MA; Pirmohamed M; Smyth RL BMC Med; 2013 Nov; 11():237. PubMed ID: 24228998 [TBL] [Abstract][Full Text] [Related]
34. A prospective analysis of the preventability of adverse drug reactions reported in Sweden. Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466 [TBL] [Abstract][Full Text] [Related]
35. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study. Shaikh SP; Nerurkar R Curr Drug Saf; 2022; 17(2):136-142. PubMed ID: 34433404 [TBL] [Abstract][Full Text] [Related]
36. Characterization of adverse drug reactions causing admission to an intensive care unit. Rojas-Velandia C; Ruiz-Garzón J; Moscoso-Alcina JC; Vallejos-Narvaéz Á; Castro-Canoa J; Bustos-Martínez Y; Flórez-Cutiva M; Contreras-Muñoz M; Gómez-Gil JC; Calderón-Ospina CA Br J Clin Pharmacol; 2017 May; 83(5):1134-1140. PubMed ID: 27905143 [TBL] [Abstract][Full Text] [Related]
37. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria. Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768 [TBL] [Abstract][Full Text] [Related]
38. Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children. Pages N; Bounabi A; Boussaha I; Ndiaye M; Portefaix A; Simeon G; Guy C; Stagnara J; Paret N; Vial T; Eftekhari P; Floret D; Gajdos V; Langhendries JP; Bleyzac N; Alberti C; Jacqz-Aigrain E; Nguyen KA; Kassai B; Therapie; 2022; 77(4):397-404. PubMed ID: 34998623 [TBL] [Abstract][Full Text] [Related]
39. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol. Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B Therapie; 2021; 76(6):675-685. PubMed ID: 33593598 [TBL] [Abstract][Full Text] [Related]
40. A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily. Nasso C; Mecchio A; Rottura M; Valenzise M; Menniti-Ippolito F; Cutroneo PM; Squadrito V; Squadrito F; Pallio G; Irrera N; Arcoraci V; Altavilla D Front Pharmacol; 2020; 11():1090. PubMed ID: 32765282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]